These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7608962)

  • 1. Susceptibility to beta-lactam agents of Yersinia enterocolitica biotype 4, serotype O3 isolated in various parts of the world.
    Pham JN; Bell SM; Hardy MJ; Martin L; Guiyoule A; Carniel E
    J Med Microbiol; 1995 Jul; 43(1):9-13. PubMed ID: 7608962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The beta-lactamases and beta-lactam antibiotic susceptibility of Yersinia enterocolitica.
    Pham JN; Bell SM; Martin L; Carniel E
    J Antimicrob Chemother; 2000 Dec; 46(6):951-7. PubMed ID: 11102414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study of the beta-lactamases of 100 clinical isolates of Yersinia enterocolitica.
    Pham JN; Bell SM; Lanzarone JY
    J Antimicrob Chemother; 1991 Jul; 28(1):19-24. PubMed ID: 1769940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of beta-lactamase production by Yersinia enterocolitica biotype 4, serotype O:3 isolated in eleven countries.
    Pham JN; Bell SM; Hardy MJ; Martin L; Guiyoule A; Carniel E
    Contrib Microbiol Immunol; 1995; 13():180-3. PubMed ID: 8833828
    [No Abstract]   [Full Text] [Related]  

  • 5. Antibiotic susceptibilities of Yersinia enterocolitica and Y. intermedia isolates from aquatic environments.
    Tzelepi E; Arvanitidou M; Mavroidi A; Tsakris A
    J Med Microbiol; 1999 Feb; 48(2):157-160. PubMed ID: 9989643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterisation of atypical biotype 3, serotype O:3 Yersinia and development of a simple identification scheme.
    Pham JN; Bell SM; Guilvout I; Martin L; Carniel E
    Eur J Clin Microbiol Infect Dis; 1996 Dec; 15(12):947-50. PubMed ID: 9031880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The detection of enzyme A of Yersinia enterocolitica by a disc diffusion method.
    Pham JN; Bell SM; Martin L; Carniel E
    Pathology; 1999 Aug; 31(3):268-70. PubMed ID: 10503276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biotype and antibiotic sensitivity of 100 clinical isolates of Yersinia enterocolitica.
    Pham JN; Bell SM; Lanzarone JY
    J Antimicrob Chemother; 1991 Jul; 28(1):13-8. PubMed ID: 1769931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection and assay of beta-lactamases in clinical and non-clinical strains of Yersinia enterocolitica biovar 1A.
    Sharma S; Ramnani P; Virdi JS
    J Antimicrob Chemother; 2004 Aug; 54(2):401-5. PubMed ID: 15269194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiological study of Yersinia enterocolitica and Yersinia pseudotuberculosis infections in Shimane Prefecture, Japan.
    Fukushima H; Tsubokura M; Otsuki K; Kawaoka Y; Nishio R; Moriki S; Nishino Y; Mototsune H; Karino K
    Zentralbl Bakteriol Mikrobiol Hyg B; 1985 May; 180(5-6):515-27. PubMed ID: 3895776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antimicrobial susceptibility of Yersinia enterocolitica and Yersinia pseudotuberculosis strains isolated from humans in Poland during 2004-2009].
    Szych J; Jakubczak A; Wardak S; Madajczak G
    Med Dosw Mikrobiol; 2009; 61(4):311-9. PubMed ID: 20201320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial susceptibility and distribution of β-lactamase A (blaA) and β-lactamase B (blaB) genes in enteropathogenic Yersinia species.
    Bonke R; Wacheck S; Stüber E; Meyer C; Märtlbauer E; Fredriksson-Ahomaa M
    Microb Drug Resist; 2011 Dec; 17(4):575-81. PubMed ID: 21970627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Susceptibility to selected antibiotics of Yersinia enterocolitica 03 strains, carrying and not carrying plasmid pYV].
    Rastawicki W; Gierczyński R; Jagielski M; Kałuzewski S; Jeljaszewicz J
    Med Dosw Mikrobiol; 1999; 51(3-4):331-7. PubMed ID: 10803262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-lactamase expression in Yersinia enterocolitica biovars 1A, 1B, and 3.
    Stock I; Heisig P; Wiedemann B
    J Med Microbiol; 2000 May; 49(5):403-408. PubMed ID: 10798551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-lactamase genes and beta-lactamic susceptibility in Yersinia enterocolitica.
    de la Prieta MC; Seoame A; Díaz J; Navas J; Garciá-Lobo JM
    Contrib Microbiol Immunol; 1995; 13():184-7. PubMed ID: 8833829
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of three molecular methods for typing and subtyping pathogenic Yersinia enterocolitica strains.
    Iteman I; Guiyoule A; Carniel E
    J Med Microbiol; 1996 Jul; 45(1):48-56. PubMed ID: 8667412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural Variabilities in β-Lactamase (blaA) of Different Biovars of Yersinia enterocolitica: Implications for β-Lactam Antibiotic and β-Lactamase Inhibitor Susceptibilities.
    Singhal N; Srivastava A; Kumar M; Virdi JS
    PLoS One; 2014; 10(4):e0123564. PubMed ID: 25919756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic and genotypic analysis of bio-serotypes of Yersinia enterocolitica from various sources in Brazil.
    Rusak LA; dos Reis CM; Barbosa AV; Santos AF; Paixão R; Hofer E; Vallim DC; Asensi MD
    J Infect Dev Ctries; 2014 Dec; 8(12):1533-40. PubMed ID: 25500651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An in-vitro study of the antimicrobial susceptibilities of Yersinia enterocolitica and the definition of a database.
    Stock I; Wiedemann B
    J Antimicrob Chemother; 1999 Jan; 43(1):37-45. PubMed ID: 10381099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Characteristics of "BlaB-Like" Chromosomal Inducible Cephalosporinase of
    Singhal N; Pandey D; Somendro Singh N; Kumar M; Virdi JS
    Microb Drug Resist; 2019; 25(6):824-829. PubMed ID: 30817214
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.